- Max Financial’s net income for the first quarter is 696.4 million rupees.
- This represents a 45% decrease compared to the same quarter last year.
- Analysts estimated the net income to be 1.33 billion rupees, indicating a significant miss on forecasts.
- The company’s revenue increased by 8.6% year-over-year to 128.2 billion rupees.
- Total costs rose by 9.5% year-over-year, reaching 127.2 billion rupees.
- Investment community response includes 22 buy ratings, 2 hold ratings, and 1 sell rating.
A look at Max India Ltd Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 1 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Max India Ltd‘s long-term outlook, as indicated by Smartkarma Smart Scores, is a mixed bag. With a Value score of 2, the company may not be considered undervalued compared to its peers. However, Max India’s Growth, Resilience, and Momentum scores of 3 each suggest positive indicators for the company’s potential growth, stability, and market performance. On the flip side, the low Dividend score of 1 indicates a lower dividend payout relative to other factors.
Max India Ltd, a subsidiary of Max Financial Services Limited, operates in the life insurance sector, providing life insurance, health insurance products, and healthcare services globally. While the company may not be viewed as a high-value investment based on the Smart Scores, its respectable scores in Growth, Resilience, and Momentum imply promising prospects in terms of future expansion, stability, and market traction.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
